Clinical Trial Update: Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate) [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of dexpramipexole on the QTc interval in healthy volunteers. The trial is sponsored by Knopp Biosciences and relates to amyo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis

Drugs mentioned

• Dexpramipexole (dexpramipexole)

Snippet

Sponsor: Knopp Biosciences | Conditions: Amyotrophic Lateral Sclerosis | Phase 1 | Status: COMPLETED